Impact of Cirrhosis Etiology on the Risk for Venous Thromboembolism

Gayatri Pemmasani1, William Tremaine2, Raffi Karagozian3

  • 1Division of Gastroenterology and Hepatology, SUNY Upstate Medical University, 750 E Adam St, Syracuse, NY, 13202, USA. gpemmasani0524@gmail.com.

Insights

Nonalcoholic steatohepatitis (NASH) cirrhosis is linked to a higher risk of venous thromboembolism (VTE) compared to alcohol-related or viral cirrhosis. Understanding this increased VTE risk in NASH cirrhosis is crucial for better patient management.

Area of Science:

  • Hepatology
  • Cardiovascular Medicine
  • Gastroenterology

Background:

  • Cirrhosis significantly elevates risks for bleeding and venous thromboembolic (VTE) events.
  • The specific impact of different cirrhosis etiologies on VTE risk remains insufficiently understood.

Purpose of the Study:

  • To investigate and compare the risk of VTE and portal venous thrombosis (PVT) across various cirrhosis etiologies, including nonalcoholic steatohepatitis (NASH), viral, and alcohol-related causes.
  • To analyze the association between cirrhosis etiology and VTE/PVT risk using a large national database.

Main Methods:

  • Retrospective analysis of the 2019 US Nationwide Readmissions Database.
  • Inclusion of hospitalized patients diagnosed with cirrhosis from NASH, viral, or alcohol-related etiologies.
  • Identification and comparison of rates for acute VTE, chronic VTE, and PVT across these etiological groups.

Main Results:

  • Nonalcoholic steatohepatitis (NASH) cirrhosis exhibited the highest overall VTE rate (10.8%), followed by viral (9.7%) and alcohol-related (7.5%) cirrhosis.
  • After risk adjustment, NASH cirrhosis (OR 1.48) and viral cirrhosis (OR 1.22) showed significantly higher VTE risk compared to alcohol-related cirrhosis.
  • Viral cirrhosis had the highest PVT rate (4.3%), with both viral (OR 1.61) and NASH cirrhosis (OR 1.41) demonstrating increased adjusted risks for PVT compared to alcohol-related cirrhosis.

Conclusions:

  • Nonalcoholic steatohepatitis (NASH) cirrhosis is associated with a significantly elevated risk of venous thromboembolism (VTE) compared to alcohol-related and viral etiologies.
  • Given the rising prevalence of NASH as a primary cause of cirrhosis, recognizing its link to increased VTE risk is vital for refining clinical management and improving patient outcomes.
Abstract

Related Concept Videos

Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
117
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
60
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
687
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
872
Venous Return01:04

Venous Return

The circulatory system plays a crucial role in ensuring the optimal functioning of the human body. One of its critical components is venous return - the process that completes the blood circulation cycle. This article will delve into the concept of venous return, how it works, and its significance to our health.
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
4.1K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
531